129 related articles for article (PubMed ID: 16601392)
1. Expression of epidermal growth factor receptor and proliferative activity of cyst epithelium in human renal cystic diseases.
Compérat E; Ferlicot S; Camparo P; Eschwege P; Ba N; Benoit G; Bédossa P; Paradis V
Urol Int; 2006; 76(3):269-73. PubMed ID: 16601392
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity of cyst epithelium in human renal cystic diseases.
Nadasdy T; Laszik Z; Lajoie G; Blick KE; Wheeler DE; Silva FG
J Am Soc Nephrol; 1995 Jan; 5(7):1462-8. PubMed ID: 7703384
[TBL] [Abstract][Full Text] [Related]
3. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
4. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
Avner ED; Woychik RP; Dell KM; Sweeney WE
Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study in acquired cystic disease of the kidney--expression of vimentin, epidermal growth factor, epidermal growth factor receptor and c-erb B2 gene product].
Horiguchi T; Ishikawa I
Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):797-807. PubMed ID: 8105122
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
7. Comparison of human polycystic and medullary cystic kidney disease with diphenylamine-induced cystic disease.
Evan AP; Gardner KD
Lab Invest; 1976 Jul; 35(1):93-101. PubMed ID: 940325
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M
Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.
Togawa H; Nakanishi K; Mukaiyama H; Hama T; Shima Y; Sako M; Miyajima M; Nozu K; Nishii K; Nagao S; Takahashi H; Iijima K; Yoshikawa N
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F511-20. PubMed ID: 21084407
[TBL] [Abstract][Full Text] [Related]
11. Cell polarity in human renal cystic disease.
Carone FA; Nakamura S; Caputo M; Bacallao R; Nelson WJ; Kanwar YS
Lab Invest; 1994 May; 70(5):648-55. PubMed ID: 8196361
[TBL] [Abstract][Full Text] [Related]
12. Morphology of cystic renal lesions. Lectin and immuno-histochemical study.
Kovács J; Zilahy M; Gomba S
Acta Chir Hung; 1997; 36(1-4):176-8. PubMed ID: 9408336
[TBL] [Abstract][Full Text] [Related]
13. EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions.
Meert AP; Martin B; Verdebout JM; Feoli F; Mascaux C; Ninane V; Sculier JP
Anticancer Res; 2006; 26(1A):135-8. PubMed ID: 16475689
[TBL] [Abstract][Full Text] [Related]
14. Atypical cysts, acquired renal cystic disease, and renal cell tumors in end stage dialysis kidneys.
Hughson MD; Hennigar GR; McManus JF
Lab Invest; 1980 Apr; 42(4):475-80. PubMed ID: 7374111
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice.
Gattone VH; Lowden DA; Cowley BD
Dev Biol; 1995 Jun; 169(2):504-10. PubMed ID: 7781894
[TBL] [Abstract][Full Text] [Related]
16. Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney disease.
Lakshmanan J; Eysselein V
Biochem Biophys Res Commun; 1993 Dec; 197(3):1083-93. PubMed ID: 8280123
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells.
Zheleznova NN; Wilson PD; Staruschenko A
Biochim Biophys Acta; 2011 Oct; 1812(10):1301-13. PubMed ID: 20959142
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
19. Explant culture of human polycystic kidney.
McAteer JA; Carone FA; Grantham JJ; Kempson SA; Gardner KD; Evan AP
Lab Invest; 1988 Jul; 59(1):126-36. PubMed ID: 3392957
[TBL] [Abstract][Full Text] [Related]
20. EGF receptor and its ligands, EGF and TGF-alpha, in developing and neoplastic human odontogenic tissues.
Heikinheimo K; Voutilainen R; Happonen RP; Miettinen PJ
Int J Dev Biol; 1993 Sep; 37(3):387-96. PubMed ID: 8292533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
